Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysis
- 8 September 2025
- journal article
- review article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 29 (1) , 57-72
Abstract
Introduction The introduction of novel robotic platforms has expanded surgical options for robot-assisted radical prostatectomy (RARP). However, comparative outcomes with da Vinci multiport (MP) system remain unclear. This systematic review and network meta-analysis aimed to compare perioperative, early oncological, and functional outcomes of RARP performed with novel robotic platforms versus the da Vinci MP system. Methods A systematic literature search was conducted in PubMed, Scopus, and Embase (updated December 22, 2024) following PRISMA guidelines. Eligible studies compared RARP performed with alternative robotic platforms versus da Vinci MP, reporting perioperative, oncological, or functional outcomes. A network meta-analysis was conducted using a random-effects model. Outcomes were expressed as mean differences for continuous variables and odds ratios (OR) for dichotomous variables, with 95% confidence intervals (CI). Results Thirty-three studies for a total of 5987 patients were included. Compared to da Vinci MP, da Vinci SP had lower odds of lymph node dissection (OR 0.39, 95% CI 0.26–0.61) and nerve-sparing (OR 0.11, 95% CI 0.02–0.61) but was associated with shorter catheterization (−1.18 days, 95% CI −2.05 to -0.31) and hospital stay (−0.68 days, 95% CI −1.05 to −0.31). Versius, KangDuo, and SHURUI SP had significantly longer operative times (MD 74.00, 95% CI 42.49–105.51; MD 53.96, 95% CI 18.26–89.67; MD 103.88, 95% CI 69.99–137.78, respectively). Hugo RAS had higher intraoperative malfunction rates (OR 6.53, 95% CI 2.17–19.63). Positive surgical margin rates were lower for da Vinci SP (OR 0.70, 95% CI 0.53–0.92) but higher with the perineal approach (OR 6.30, 95% CI 1.53–25.94). PSA persistence, biochemical recurrence, continence and erectile function rates were comparable across platforms. Conclusion This is the first network meta-analysis comparing robotic platforms for RARP. While perioperative differences exist, oncological and functional outcomes appear comparable. Future studies should address learning curve effects, cost-effectiveness, and long-term functional outcomes to optimize robotic platform selection.Keywords
This publication has 56 references indexed in Scilit:
- Comparison of Robot‐Assisted Laparoscopic Prostatectomy Using the Made‐in‐Japan Robotic System Hinotori Versus Da Vinci: A Propensity Score‐Matched AnalysisThe International Journal of Medical Robotics and Computer Assisted Surgery, 2024
- Retzius sparing robot-assisted radical prostatectomy: optimizing functional resultsWorld Journal of Urology, 2024
- Radical prostatectomy using the Hinotori robot‐assisted surgical system: Docking‐free design may contribute to reduction in postoperative painThe International Journal of Medical Robotics and Computer Assisted Surgery, 2024
- Da Vinci vs. Hugo RAS for robot-assisted radical prostatectomy: a prospective comparative single-center studyWorld Journal of Urology, 2024
- Skills transfer from the DaVinci® system to the Hugo™ RAS systemInternational Urology and Nephrology, 2023
- Comparison between intra- and postoperative outcomes of the da Vinci SP and da Vinci Xi robotic platforms in patients undergoing radical prostatectomyJournal of Robotic Surgery, 2023
- Perioperative, functional, and oncologic outcomes of robot-assisted versus open partial nephrectomy for complex renal tumors (RENAL score ≥ 7): an evidence-based analysisJournal of Robotic Surgery, 2023
- Comparison of single-port and multi-port Retzius-sparing robot-assisted laparoscopic prostatectomyJournal of Robotic Surgery, 2022
- Market potentials of robotic systems in medical science: analysis of the Avatera robotic systemWorld Journal of Urology, 2021
- Radical prostatectomy technique in the robotic evolution: from da Vinci standard to single port—a single surgeon pathwayJournal of Robotic Surgery, 2021